Page 6 - Oene Mark Van News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Oene mark van. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Oene Mark Van Today - Breaking & Trending Today

Pacific Biosciences of California, Inc. (NASDAQ:PACB) Given Average Recommendation of "Moderate Buy" by Brokerages

Pacific Biosciences of California, Inc. (NASDAQ:PACB) Given Average Recommendation of "Moderate Buy" by Brokerages
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United States , Oene Mark Van , Pacific Biosciences , Davidw Meline , Barclays Plc , Wolfe Research , Securities Exchange Commission , Exome Asset Management , Faithward Advisors , Virtu Financial , California Inc , Group Plc , Get Free Report , Marketbeat Ratings , California Trading Down , Director David , Exchange Commission , Asset Management , General Group Plc , Get Free , California Daily ,

Nordea Investment Management AB Purchases 40,667 Shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB)

Nordea Investment Management AB raised its position in Pacific Biosciences of California, Inc. (NASDAQ:PACB – Free Report) by 37.5% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 149,131 shares of the biotechnology company’s stock after purchasing an additional 40,667 shares during the quarter. […] ....

United States , New Jersey , Oene Mark Van , Pacific Biosciences , Christiano Henry , California Inc , Exchange Commission , Jump Financial , California Company Profile , Jersey Common Pension Fund , Td Asset Management Inc , Wolfe Research , Canaccord Genuity Group , York Mellon Corp , Nordea Investment Management , Free Report , Investment Management , Management Inc , New York Mellon Corp , Genuity Group , California Price , Get Free Report , California Company , Visit Holdingschannel , California Daily , Pacific Biosciences Of California ,

Pacific Biosciences of California, Inc. (NASDAQ:PACB) Insider Oene Mark Van Sells 33,560 Shares

Pacific Biosciences of California, Inc. (NASDAQ:PACB – Get Free Report) insider Oene Mark Van sold 33,560 shares of the company’s stock in a transaction dated Friday, February 16th. The shares were sold at an average price of $5.96, for a total transaction of $200,017.60. Following the completion of the transaction, the insider now owns 876,611 […] ....

United States , Pacific Biosciences , Oene Mark Van , Securities Exchange Commission , Wolfe Research , Jump Financial , York Mellon Corp , Td Asset Management Inc , California Inc , Morgan Stanley , Cantor Fitzgerald , Fdx Advisors Inc , Get Free Report , Exchange Commission , Mark Van , California Price , Management Inc , New York Mellon Corp , California Daily , Pacific Biosciences Of California , Nasdaq Pacb , Insider Trading , Nsider Trades ,

Pacific Biosciences of California (NASDAQ:PACB) Reaches New 52-Week Low at $5.27

Shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB – Get Free Report) hit a new 52-week low during mid-day trading on Tuesday . The stock traded as low as $5.27 and last traded at $5.33, with a volume of 1917605 shares. The stock had previously closed at $5.74. Analyst Upgrades and Downgrades A number of […] ....

United States , Pacific Biosciences , Christiano Henry , Piper Sandler , Oene Mark Van , Morgan Stanley , Comerica Bank , California Inc , Securities Exchange Commission , Kayne Anderson Rudnick Investment Management , Wolfe Research , Fairfield Bush , Get Free Report , California Price , Exchange Commission , Investors Weigh In On Pacific Biosciences , Financial Advisors , California Daily , Pacific Biosciences Of California , Nasdaq Pacb ,

Pacific Biosciences of California (NASDAQ:PACB) Releases Quarterly Earnings Results, Beats Expectations By $0.02 EPS

Pacific Biosciences of California (NASDAQ:PACB – Get Free Report) issued its quarterly earnings results on Thursday. The biotechnology company reported ($0.27) EPS for the quarter, beating analysts’ consensus estimates of ($0.29) by $0.02, RTT News reports. The company had revenue of $58.36 million for the quarter, compared to analyst estimates of $57.96 million. Pacific Biosciences […] ....

United States , Christiano Henry , Oene Mark Van , Pacific Biosciences , Prudential Financial Inc , Fairfield Bush , California Company Profile , Canaccord Genuity Group , Comerica Bank , Morgan Stanley , California Inc , Wolfe Research , Get Free Report , California Stock , Funds Weigh In On Pacific Biosciences , Financial Advisors , Prudential Financial , Genuity Group , California Company , California Daily , Pacific Biosciences Of California , Nasdaq Pacb ,